Top Markets
Coin of the day
Oxford Cannabinoid Technologies Holdings Plc Oxford Cannabinoid Technologies Holdings Plc

Oxford Cannabinoid Technologies Holdings Plc

OCTP
Classifica tra le azioni #41532
Oxford Cannabinoid Technologies Holdings Plc operates as a pharmaceutical... Oxford Cannabinoid Technologies Holdings Plc operates as a pharmaceutical company, focused on the research, development, and commercialization of cannabinoid-derived prescription medications. Their principal drug candidate, OCT461201, is a selective CB2 receptor agonist in an oral solid dosage format, currently undergoing pre-clinical assessment. It is being developed to target visceral pain associated with Irritable Bowel Syndrome (IBS), as well as a range of neuropathic pain conditions, notably post-herpetic neuralgia. The company is also progressing with OCT130401, another compound in pre-clinical development, intended for the treatment of trigeminal neuralgia. Incorporated in 2017, Oxford Cannabinoid Technologies Holdings Plc is based in London, United Kingdom.
Prezzo delle azioni
$0.00156481
Ultima sincronizzazione: 2024-06-05
Capitalizzazione di mercato
$17.03K
Variazione (1 giorno)
2.11%
Variazione (1 anno)
0.00%
Paese
GB
Scambia Oxford Cannabinoid Technologies Holdings Plc (OCTP)

Categoria

Storico del prezzo dell'azione per Oxford Cannabinoid Technologies Holdings Plc (OCTP)
Prezzo di chiusura più alto: $0.00 il 2024-06-01

Prezzo di chiusura più basso: $0.06 il 2021-05-01
Storico del prezzo dell'azione di Oxford Cannabinoid Technologies Holdings Plc dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2024 -83.26%
2023 21.25%
2022 -77.28%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$527.87 33.33%
US
$873.57 35.10%
NL
$741.32 8.41%
CH
$1.08K -6.68%
KR
$258.23 15.91%
BE